Gemphire Therapeutics
$0.45819876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.4581
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.0045 (-0.97%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell GEMP and other stocks, options, ETFs, and crypto commission-free!
About GEMP
Gemphire Therapeutics Inc. Common Stock, also called Gemphire Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. Read More It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI.
Employees
9
Headquarters
Livonia, Michigan
Founded
2014
Market Cap
6.81M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
80.23K
High Today
$0.4668
Low Today
$0.4461
Open Price
$0.4578
Volume
32.06K
52 Week High
$2.52
52 Week Low
$0.4211
Collections
Price Paid on Robinhood
81% Lower
Right Now
52 Week Low
$0.5698
Average Price Paid
$2.42
52 Week High
$11.43
GEMP Earnings
-$0.66
-$0.51
-$0.35
-$0.20
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 7, Pre-Market